James F Cleary
Affiliation: University of Wisconsin
- The pharmacologic management of cancer painJames F Cleary
Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA
J Palliat Med 10:1369-94. 2007..Much of the work obtained from the study of cancer patients is applicable to the non cancer populations, as is work performed in non cancer patients with neuropathic pain...
- Communicating advanced cancer patients' symptoms via the Internet: a pooled analysis of two randomized trials examining caregiver preparedness, physical burden, and negative moodMing Yuan Chih
Department of Industrial and Systems Engineering, University of Wisconsin Madison, Madison, WI, USA
Palliat Med 27:533-43. 2013..Using available communication technologies, clinicians may offer timely support to family caregivers in managing symptoms in patients with advanced cancer at home...
- Multivariate analysis of countries' government and health-care system influences on opioid availability for cancer pain relief and palliative care: more than a function of human developmentAaron M Gilson
Pain and Policy Studies Group, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, USA
Palliat Med 27:105-14. 2013..Although opioids such as morphine are considered essential medicines in the provision of palliative care and for treating cancer pain, especially when the pain is severe, low- and middle-income countries often lack such medications...
- An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trialDavid H Gustafson
Center for Health Enhancement Systems Studies, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
Cancer 119:1744-51. 2013....
- Caregivers' participation in the oncology clinic visit mediates the relationship between their information competence and their need fulfillment and clinic visit satisfactionLori L DuBenske
University of Wisconsin Madison, Center for Health Enhancement Systems Studies, Madison, WI 53726, USA
Patient Educ Couns 81:S94-9. 2010..This study examines the mediating role caregiver's clinic visit involvement has on the relationships between caregiver's information competence and their need fulfillment and clinic visit satisfaction...
- Creating a bond between caregivers online: effect on caregivers' coping strategiesKang Namkoong
School of Journalism and Mass Communication, and Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin 53706, USA
J Health Commun 17:125-40. 2012..Findings suggest that perceived bonding has positive effects on caregivers' appraisal and problem-focused coping strategies, and it mediates the effect of ICCS on the coping strategies 6 months after the intervention has begun...
- Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?Gabrielle B Rocque
University of Wisconsin, Carbone Cancer Center, Hematology Oncology, K6 518, 600 Highland Ave, Madison, WI 53729, USA
J Oncol Pract 9:51-4. 2013..Many patients receive aggressive, in-hospital end-of-life care at high cost. There are few data on outcomes after unplanned hospitalization of patients with metastatic cancer...
- Using a morphine equivalence metric to quantify opioid consumption: examining the capacity to provide effective treatment of debilitating pain at the global, regional, and country levelsAaron M Gilson
Pain and Policy Studies Group, University of Wisconsin Carbone Cancer Center, Madison, WI, USA
J Pain Symptom Manage 45:681-700. 2013..Understanding opioid consumption is improved by using an equianalgesic measure that controls for the strengths of all examined opioids...
- Development and implementation of a clinician reporting system for advanced stage cancer: initial lessons learnedLori L DuBenske
Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin, USA
J Am Med Inform Assoc 15:679-86. 2008..This study reports initial findings from implementation of the Clinician Report (CR)-a patient and caregiver status report tool accessible by the oncology clinic team...
- Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancerPaul R Hutson
School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705 2222, USA
Clin Cancer Res 11:8722-7. 2005..Clinical trials combining tamoxifen with letrozole or anastrazole have shown minor pharmacokinetic drug interactions. We did an open-label crossover clinical trial of the effect of exemestane on tamoxifen pharmacokinetics...
- Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancerRichard R Love
Department of Medicine, University of Wisconsin, 610 Walnut Street, 256 Warf Office Building, Madison, WI 53726, USA
Clin Cancer Res 11:1500-3. 2005..To evaluate the endocrine effects of the combination of exemestane and tamoxifen, we studied 33 postmenopausal women disease-free following primary treatments for breast cancer who were taking tamoxifen for at least 3 months...
- Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignanciesSteven Attia
University of Wisconsin Paul P Carbone Comprehensive Cancer Center Madison, Madison, WI 53792, USA
Cancer Chemother Pharmacol 64:45-51. 2009..To define dose limiting toxicities (DLTs) and the maximum tolerated dose (MTD) of capecitabine with fixed-dose rate (FDR) gemcitabine...
- Web-based cancer communication and decision making systems: connecting patients, caregivers, and clinicians for improved health outcomesLori L DuBenske
School of Medicine and Public Health, Department of Psychiatry, University of Wisconsin Madison, USA
Med Decis Making 30:732-44. 2010..Implementation strategies should address timing, personnel, and environmental factors to facilitate continued use and benefit from IHCS...
- Cancer information sources used by patients to inform and influence treatment decisionsMatthew C Walsh
Paul P Carbone Comprehensive Cancer Center, and Department of Population Health Sciences, University of Wisconsin Madison, Madison, Wisconsin, USA
J Health Commun 15:445-63. 2010..These findings provide a deeper understanding of the information needs of cancer patients and have implications for dissemination strategies that can minimize disparities in access to cancer information...
- Examining influences on the availability of and access to opioids for pain management and palliative careMartha A Maurer
Pain and Policy Studies Group PPSG of the University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53706, USA
J Pain Palliat Care Pharmacother 27:255-60. 2013..Recent authoritative statements and activities suggest a strengthened infrastructure within which governments currently can work to improve the availability of controlled medicines to enhance patient pain and palliative care services...
- Palliative care reduces morbidity and mortality in cancerGabrielle B Rocque
Hematology Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI 53792, USA
Nat Rev Clin Oncol 10:80-9. 2013..Through collaboration between oncologists and palliative care teams, there is hope of improving the quality of care for patients with both curable and life-limiting cancers...
- Materials to prepare hospice families for dying in the homeKaren A Kehl
School of Nursing, University of Wisconsin, Madison, Wisconsin 53792 2455, USA
J Palliat Med 11:969-72. 2008..1%), surge of energy (11.8%) and mandibular breathing (5.9%). Hospice staff should know the content of the materials offered by their agency so they can verbally address the gaps between the written materials and family needs...
- Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experienceAnne M Traynor
Section of Hematology and Medical Oncology, University of Wisconsin, Paul P Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Head Neck 32:599-606. 2010....
- Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practicesMarla Z Wolfert
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin WI 53792, USA
Pain Med 11:425-34. 2010..Although their role in the management of chronic pain not related to cancer is controversial, there is increasing evidence for their benefit in certain patient populations...
- Caregivers' differing needs across key experiences of the advanced cancer disease trajectoryLori L DuBenske
Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin 53706, USA
Palliat Support Care 6:265-72. 2008..This study examines a variety of particular needs across a number of more discrete illness-related transition experiences specifically in the advanced cancer disease trajectory...
- Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridolJames P Thomas
University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Ave, Madison, WI 53792, USA
Cancer Chemother Pharmacol 50:465-72. 2002..We conducted a phase I trial and pharmacokinetic study of flavopiridol given as a 72-h continuous intravenous infusion repeated every 2 weeks...
- Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policyAaron M Gilson
University of Wisconsin Carbone Cancer Center, 1300 University Avenue, Madison, WI 53706, USA
J Pain Palliat Care Pharmacother 25:246-51. 2011..It is hoped that representatives of governments and medical institutions, as well as health care professionals, will commonly and effectively use the revised WHO guidelines as a policy change tool...
- Integrating palliative care into head and neck oncologyJames F Cleary
University of Wisconsin Paul P Carbone Comprehensive Cancer Center, Madison, WI 53792, USA
Int J Radiat Oncol Biol Phys 69:S83-5. 2007
- Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapyNoelle K Loconte
University of Wisconsin Paul P Carbone Comprehensive Cancer Center, 600 Highland Ave, CSC K4 548, Madison, WI 53792, USA
Cancer Chemother Pharmacol 65:775-80. 2010..The goal of this study was to identify clinical and nonclinical factors which were associated with the development of DLT in phase I studies...
- Predictors of hospice utilization among acute stroke patients who died within thirty daysAmanda E duPreez
Center for Women s Health Research, University of Wisconsin School of Medicine and Public Health and Meriter Hospital, Madison, Wisconsin 53726, USA
J Palliat Med 11:1249-57. 2008..The highest mortality among stroke patients occurs within the first 30 days; however, we know little about the hospice enrollment decision for this population during this critical time frame...
- Patient/Caregiver influences for declining participation in supportive oncology trialsMary K Buss
Division of Hematology Oncology and Palliative Care Consultation Service, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rose 144, Boston, MA 02215, USA
J Support Oncol 6:168-74. 2008..This information was specific to supportive care trials; it may help researchers plan recruitment strategies and enrollment targets...
- A day in the life of European palliative careJames F Cleary
Palliat Med 19:442-3. 2005
- Incident painJames F Cleary
Palliat Med 19:1-2. 2005
- Consensus statement: Palliative and supportive care in advanced heart failureSarah J Goodlin
Institute for Health Care Delivery and Research, Intermountain Health Care, Salt Lake City, Utah 84111, USA
J Card Fail 10:200-9. 2004..A consensus conference was convened to define the current state and important gaps in knowledge and needed research on "Palliative and Supportive Care in Advanced Heart Failure."..